Pathology
of human malignant
mesothelioma--preliminary analysis of
1,517 mesothelioma
cases.
The
author reviewed 1,517 human malignant
mesothelioma cases from 1975 through
August 2000. These mesothelioma cases
were definite or probable in diagnostic
certainty. Sources of these cases
varied including asbestos insulation
workers, UNARCO workers, Cancer and
Leukemia B mesothelioma panel cases and
random cases. - Ind
Health 2001 Apr;39(2):183-5
Treatment
of malignant
mesothelioma.
Malignant
pleural mesothelioma (MPM) is a rare
tumor that predominantly afflicts men
over 50 years of age. Nearly 3000 MPMs
are reported annually in the United
States with the incidence expected to
rise into the new millenium. -
World
J Surg 2001 Feb;25(2):210-7
Advances
in the treatment of malignant pleural
mesothelioma
This
review will discuss the roles of
chemotherapy, radiotherapy, surgery,
and combined modality approaches in the
treatment of pleural mesothelioma, as
well as scientific advances made in the
past decade that have led to the
development of experimental techniques,
such as photodynamic therapy,
immunotherapy, and gene therapy, that
are currently undergoing human clinical
trials. - Chest
1999 Aug;116(2):504-20
Current
Therapy For Mesothelioma
Expert
Dr. Sugarbaker and his associates in
Boston have published a study of
Current Therapy options and predicting
survival for malignant mesothelioma
victims.
A
Letter from Dr. Lary A.
Robinson
Dr.
Lary A. Robinson, from the H. Lee
Moffitt Cancer Center and Research
Institute, shares with Jim Early the
center's strong interest and experience
in the evaluation and treatment of
malignant pleural mesothelioma of all
stages.